Lv1
20 积分 2025-07-17 加入
Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer
8小时前
已完结
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
7天前
已完结
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
2个月前
已完结
Coming of age: mRNA vaccines for orthoflaviviruses
2个月前
已完结
EGFR -Mutated Lung Cancer — Letting the Butterfly Out of the Cocoon
2个月前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
2个月前
已完结
Beyond the Guided Missile Paradigm: Embracing the Complexity of Antibody-Drug Conjugates
2个月前
已完结
Pattern of failure, impact of local therapy, and characteristics of long-term responders with advanced EGFR mutation positive non-small cell lung cancer treated with first-line osimertinib
2个月前
已关闭
Rethinking Survival Metrics in EGFR-Mutated NSCLC: Insights from RMST Analysis of FLAURA2 and MARIPOSA
2个月前
已关闭
TROP2-Directed Antibody-Drug Conjugates in Advanced Non–Small Cell Lung Cancer: A Fading Hope?
3个月前
已完结
皖公网安备34019202002308
